Hiroaki Nishimatsu
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world study.
Journal: Japanese journal of clinical oncology
Published: May 22, 2026
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: September 21, 2024
Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: June 02, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.
Journal: Immunotherapy
Published: May 16, 2023
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
Journal: World journal of urology
Published: September 12, 2022
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: May 25, 2022
Incomplete sagittal septum of the bladder with cystolithiasis.
Journal: IJU case reports
Published: February 09, 2022
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis.
Journal: Journal for immunotherapy of cancer
Published: January 31, 2022
Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.
Journal: Scientific reports
Published: May 28, 2021
Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
Journal: Japanese journal of clinical oncology
Published: February 11, 2021
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Journal: International journal of clinical oncology
Published: June 28, 2020
Last Updated: 09/26/2026